The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.
Translational Research, Medical Oncology, Cancer Prevention, Control and Outcomes, Immunotherapy, Molecular Diagnostics and Therapy, and Integrative Radiation Oncology
Das Nationale Centrum für Tumorerkrankungen (NCT) Heidelberg vereinigt Patientenversorgung, Krebsforschung und Krebsprävention unter einem Dach, um alle für den Kampf gegen Krebs relevanten Aspekte zu berücksichtigen.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Gustave Roussy Health, Hospitals and Health Care | Gustave Roussy Health, Hospitals and Health Care | Other 24 Oct 2023 | | |
Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 30 Jun 2023 | | |
SAP IT services, Software, Software Development | SAP IT services, Software, Software Development | Other 30 Jun 2023 | |